Clinical Trial Update: Clinical Study of ICP-192 in Solid Tumors Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ICP-192 in solid tumors across Phase 1 and Phase 2, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• ICP-192

Snippet

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN